NASHVILLE, Tenn. & ORANGE, Calif. & ATLANTA & BOSTON, Oct. 10, 2023 – A large multi-state study by the Centers for Disease Control and Prevention, the Harvard Pilgrim Health Care Institute, HCA Healthcare, and the University of California, Irvine has found that a nasal antibiotic ointment, mupirocin, which is currently…Read More
Related Posts
Athira Pharma Inc Athira Pharma Presents Preclinical Data Highlighting Fosgonimetons Neuroprotective Effects Against AmyloidInduced Pathological…
BOTHELL, Wash., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration,…
Survey of allergistsimmunologists reveals management of hereditary
ARLINGTON HEIGHTS, Ill. (April 5, 2023) - Hereditary angioedema (HAE) is a disease that, due to its rare nature, can pose difficulties for both patients and medical professionals. A new…
Indivior to Commence Trading on Nasdaq Indivior OTCINVVY
RICHMOND, Va., June 12, 2023 /PRNewswire/ -- Indivior PLC INDV, a global pharmaceutical company working to help change patients' lives by developing medicines to treat substance use disorders (SUD) and…
